Manchester Airport sees a busy sequence of heavy jet action with an Airbus A380, go-arounds, VOR approaches, and sunset arrivals creating a tense aviation mix. The changing light and approach traffic ...

Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

I’ve been wearing Salomons on and off since I was a teen, but as my most recent pair of basic black XT Wings nears their end (after an impressive six-year run), I’m ready to move on. After considering ...

In December, Howard Marks published an investment memo titled, “Is it a bubble?” that expressed some of his skepticism and reservations about artificial intelligence and the stock-market boom it had ...

Howard Marks is much less skeptical about AI than he was just a few months ago. In December, Howard Marks published an investment memo titled, "Is it a bubble?" that expressed some of his skepticism ...

Vor Biopharma Inc. (VOR) stock jumped to a high of $12 yesterday, gaining >20%, but as I discovered to my detriment recently, all is not exactly what it seems at the company. In this post I revisit a ...

Vor Biopharma Inc. (VOR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

BOSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the ...

RemeGen and Vor Bio have reported a phase 3 trial win for telitacicept in IgA nephropathy. It is the second phase 3 success for the therapy in the last two weeks, with the other coming in Sjögren’s ...

Dallan Murray joins a C-suite that Vor Bio has rebuilt quickly in recent months to support a sharp change in direction. (Nuthawut Somsuk/Getty Images) Vor Bio has handed Dallan Murray a swift return ...